Literature DB >> 21506068

A laparoscopic approach to ventriculoperitoneal shunt placement with a novel fixation method for distal shunt catheter in the treatment of hydrocephalus.

Y Shao1, M Li, J-L Sun, P Wang, X-k Li, Q-L Zhang, L Zhang.   

Abstract

BACKGROUND: The laparoscopically assisted ventriculoperitoneal (VP) shunt has been widely used in the clinical treatment of hydrocephalus for its simplicity and reliability. Despite significant improvements in shunt procedures, shunt complications remain common. Our clinical experiences suggest that the fixation of the distal (peritoneal) shunt catheter using threads and hemoclips may partially contribute to complications of the distal shunt including obstruction of the shunt and infection. In this study, we explored a novel fixation method in the laparoscopically assisted VP shunt with use of the liver falciform ligament as a natural support for fixation of the distal shunt catheter.
METHODS: 10 patients with hydrocephalus underwent laparoscopically assisted VP shunt and the distal shunt catheter was placed into the hepatodiaphragmatic space and the catheter was traversed through 2-3 drilled holes in the liver falciform ligament without using any artificial material for fixation.
RESULTS: In all the patients who received surgery with the adopted new procedure the clinical symptoms were alleviated. The size of cerebral ventricles returned to normal after 1 week. The distal catheters were in the hepatodiaphragmatic space in 9 of 10 patients, while in 1 patient it migrated to the peritoneal cavity underneath the liver. All the 9 patients were followed up for 1 year and no surgery-related catheter obstructions and infections were observed.
CONCLUSIONS: The modified laparoscopically assisted VP shunt in the treatment of hydrocephalus with fixation of the distal shunt catheter to a natural anatomic structure could potentially reduce the necessity of repeat surgery for addressing the complications caused by catheter obstruction and infections, reduce the chance of adhesions, and would be of benefit to those patients who need future revisions. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21506068     DOI: 10.1055/s-0031-1271680

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN: 0946-7211


  6 in total

Review 1.  Applications of hepatic round ligament/falciform ligament flap and graft in abdominal surgery-a review of their utility and efficacy.

Authors:  Vasudevan Baskaran; Jayant Kumar Banerjee; Sita Ram Ghosh; Sukumar Santosh Kumar; Subramaniam Anand; Govind Menon; Deep Shikha Mishra; Ramanathan Saranga Bharathi
Journal:  Langenbecks Arch Surg       Date:  2021-01-07       Impact factor: 3.445

Review 2.  Laparoscopy for ventriculoperitoneal shunt implantation and revision surgery.

Authors:  Fernando Campos Gomes Pinto; Matheus Fernandes de Oliveira
Journal:  World J Gastrointest Endosc       Date:  2014-09-16

3.  Risk factors associated with distal catheter migration following ventriculoperitoneal shunt placement.

Authors:  Kingsley O Abode-Iyamah; Ryan Khanna; Zachary D Rasmussen; Oliver Flouty; Nader S Dahdaleh; Jeremy Greenlee; Matthew A Howard
Journal:  J Clin Neurosci       Date:  2015-11-06       Impact factor: 1.961

4.  A Retrospective Analysis of Ventriculoperitoneal Shunt Revision Cases of a Single Institute.

Authors:  Man-Kyu Park; Myungsoo Kim; Ki-Su Park; Seong-Hyun Park; Jeong-Hyun Hwang; Sung Kyoo Hwang
Journal:  J Korean Neurosurg Soc       Date:  2015-05-31

5.  Ventriculoperitoneal shunting: Laparoscopically assisted versus conventional open surgical approaches.

Authors:  Fares Nigim; Ajith J Thomas; Efstathios Papavassiliou; Benjamin E Schneider; Jonathan F Critchlow; Clark C Chen; Jeffrey J Siracuse; Pascal O Zinn; Ekkehard M Kasper
Journal:  Asian J Neurosurg       Date:  2014-04

6.  Novel type of peritoneocentesis trocar-assisted distal ventriculoperitoneal shunt placement with supervision via a one-port laparoscope.

Authors:  Guangming Wang; Jinlu Yu; Yongxin Luan; Yanwu Han; Shuanglin Fu
Journal:  Exp Ther Med       Date:  2017-08-14       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.